WANY
MIST icon

Wealthspire Advisors (New York)’s Milestone Pharmaceuticals MIST Stock Holding History

Wealthspire Advisors (New York)’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6K Buy
+10,629
New +$18.6K ﹤0.01% 928
2025
Q4 		– Sell
-1,129
Closed -$2.26K – 2152
2025
Q3 		$2.26K Buy
+1,129
New +$1.99K ﹤0.01% 2577

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Wealthspire Advisors (New York)'s MIST Position: Q1 2026 in Review

Wealthspire Advisors (New York) opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 10,629 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #928 among its holdings. This is a return to the name: Wealthspire Advisors (New York) previously reported a position in MIST as recently as Q3 2025.

Wealthspire Advisors (New York) first reported a position in MIST in Q3 2025 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Wealthspire Advisors (New York) held 10,629 shares of Milestone Pharmaceuticals worth $12.6K as of Q1 2026.
  • Milestone Pharmaceuticals was a new Wealthspire Advisors (New York) position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #928 holding.
  • Wealthspire Advisors (New York) first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.